KEYNOTE SPEAKERS
Mike Dethick, LLB
Managing Director, R&D-Based Pharmaceutical Association Committee, Beijing, China
Luca Genovese, AMID
Researcher, Access to Medicine Foundation, Amsterdam, Netherlands
Hervé Gisserot
Senior Vice President and Head of Pharmaceuticals Asia Pacific, GlaxoSmithKline, Former Senior Vice President and General Manager of Pharmaceuticals and Vaccines, GlaxoSmithKline (China), Former President, Leem, Singapore
Kent Kedl, MA
Senior Partner, Control Risks, Former Vice President and General Manager, Technomic Asia, Shanghai, China
George “Ren” McEachern, CFE, CAMS
Supervisory Special Agent, International Corruption Squad, US Federal Bureau of Investigation, Washington, DC, USA
Jean-Christophe Pointeau
Country Chair, Sanofi China, Board Member, JHL Biotech, Former President, China, Bristol-Myers Squibb, Shanghai, China
Professor Huang Yong
Competition Law Center, University of International Business and Economics, Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, Peoples Republic of China, Beijing, China
CO CHAIRS
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore
Maija Burtmanis, LLB/BSc LLM
Regional Compliance Director, Japan / Asia Pacific, Shire, Former Healthcare CO, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate GC, Alcon Russia, Former Asia Pacific, Country CO, Novartis SG, Singapore
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics, Former Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
FEATURING A PRECONFERENCE
- Training in Compliance and Ethics Basics
PLENARY SESSIONS
- Keynote: Hervé Gisserot, SVP and Head of Pharmaceuticals, Asia Pacific, GSK
- Keynote: Jean-Christophe Pointeau, Country Chair, Sanofi China
- Keynote: Prof Huang Yong, Competition Law Center, Univ of Int’l Business and Economics
- Keynote: George “Ren” McEachern, CFE, CAMS, Supervisory Special Agent, FBI
- Global Chief Compliance Officer Roundtable
- Managing Pharma & Device Risk Across the Asia Pacific Region
- Asia Pac Anticorruption Update Roundtable
- Asia Pac Public-Private Pharmaceutical Partnerships
- The Chinese Anti-unfair Competition Law
- RDPAC Pharmaceutical Enterprise Ethical Business Practice
- AdvaMed’S Code of Ethics on Interactions with HCPs in China
- The Continued Evolution of Compliance as a Profession
- Pharmaceutical Compliance and Access to Medicine
- Roundtable on New Directions in Compliance Innovation
AND MINI SUMMITS
- Chinese Anticorruption and Compliance Best Practices Roundtable
- Asia Pac Medical Device Compliance Regulatory Developments and Burning Issues
- Separation and Collaboration between Medical Education and Product Promotion
- Organizational Justice: One of the Pillars of a Culture of Integrity
- Transparency Reporting to Prevent Corruption Risk
- How to Eliminate Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
- Korean Anticorruption and Compliance Best Practices Roundtable
- Global Data Privacy Update and the Impact to the Life Sciences Industry
- The Art of the Investigation: Planning, Executing and Completing Investigations
- The Evolution of Compliance Organizations
- Third Party Management, including Due Diligence, Contracting, Monitoring and Payment
- When Will You Deploy Robot(s) in your Compliance Team?
- Compliance and Ethical Issues in Patient Support Programs and Patient Advocacy Organizations
- Fraud Trends in Asia Pacific and How Companies are Dealing with Them
FEATURED FACULTY
Ted Acosta, Esq.
Americas Vice Chair, Risk Management, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA
M. Jason Brooke, JD
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance, and Investigations, Navigant, Former Board Member and General Counsel, Vasoptic Medical, Inc., Washington, DC, USA
Brian Caster, JD
APAC Regional Compliance Investigations Lead, Pfizer, Tokyo, Japan
Eric Carlson, JD
Partner, Covington & Burling LLP, Shanghai, China
Stacy Chai
Partner, Fraud Investigation & Dispute Services, Ernst & Young LLP, Singapore
Calvin Chan, LLB, LLM
Partner, International Disputes and Investigations, Reed Smith, Singapore
Praween Chantanakomes, JD
Senior Associate, Baker & McKenzie, Bangkok, Thailand
Chi Chen
Forensic Technology Partner, Ernst & Young LLP, Shanghai, China
Vivian Chen, LLB
Head of Compliance, Alcon Laboratories China, A Novartis Division, Former Head of Ethic and Compliance, Greater China, Baxter Intl Inc., Beijing, China
Stephanie Chew
Head, Ethics and Compliances, Medtronic Greater China, Former Senior Manager Commercial Assurance Greater China/Central Asia, Becton Dickinson, Shanghai, China
Kyungsun Kyle Choi
Senior Foreign Legal Consultant, Kim & Chang Law Firm, Seoul, South Korea
Steven Chon, MA
Director, Fraud Investigation & Dispute Services (Hong Kong & Korea), Ernst & Young LLP, Hong Kong
Hwee Ping Chua, LLB, LLM
Associate Vice President, International Legal & Compliance, Asia Pacific, China & Japan, Merck, Former Regional Counsel, Asia Pacific, Bristol-Myers Squibb, Singapore
Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea
Myung Soon Chung, Esq.
Partner, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore
Karen Eryou
Head, Ethics AND Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division, Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
J. Mark Farrar, CPA, CFE, CFF
Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA
Chris Fordham
Managing Partner, Asia Pacific Area, Fraud Investigation, and Dispute Services, Ernst & Young LLP, Hong Kong
Ronald Goon
Senior Director, Business Practices & Compliance, Johnson & Johnson, Singapore
Mohit Grover
Executive Director, Risk Consulting, Deloitte; Former Regional Chief Information Officer, Astra Zeneca Asia Pacific, Singapore
Winnie Ho
Partner, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong and Shanghai, China
Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
Christine Hu, LLM
Legal and Compliance Director, Medtronic Kanghui Orthopedics, Former Legal, Compliance & Government Affair Director, Zimmer, Beijing, China
Jennifer Jiang
APAC Internal Audit Director, AstraZeneca, Shanghai, China
Vanessa Han Jun
Head of Compliance, China, Novo Nordisk, Shanghai, China
Jasmine Karimi, LLM
Senior Director & Counsel, APAC Illumina Inc., Immediate past President, Hong Kong Corporate Counsel Association, Singapore
Yota Kikuchi
Director, Compliance Rules & Management, Japan Pharma Business Unit, Takeda Pharmaceuticals, Member, Code Compliance Committee, Japan Pharmaceutical Manufacturers Association, Member, IFPMA Ethics & Business Integrity Committee (eBIC), Tokyo, Japan
Sarah Kochling
Managing Principal, Blossom Innovation, Board of Directors, American Chamber of Commerce, Shanghai, Shanghai, China
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
David Kurlander, MBA
Vice President, Health Care Compliance, Privacy, FCPA, Ortho Clinical Diagnostics, Former Finance Director, Tax and Commercial Compliance, Ethicon, A Johnson and Johnson Company, New York, NY, USA
Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China
Yunjoh Lee, LLM
Attorney, Kim & Chang, Seoul, South Korea
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
Howard Lin
Vice President, Ethics & Compliance – Lilly China, Eli Lilly and Company, Hong Kong
Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA
Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore
Christine Ng
Head, Ethics & Compliance Officer, Greater China, GSK, Shanghai, China
Jennie Orrico, JD
Senior Vice President, Chief Compliance and Risk Officer, Shire, Vice President and Associate General Counsel, Compliance, Baxalta Incorporated, Chicago, IL, USA
Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore
Clarissa Shen
China Head, Global Ethics & Business Integrity, Sanofi Group, Former Associate Compliance, Director, Eli Lilly China, Shanghai, China
Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/ Sustainability), Legal/International Compliance and Risk Management Professional, Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Singapore and Delhi, India
John Tan, JD
Partner, ReedSmith, Former China Regional Compliance Director, Pfizer, Shanghai, China
Geeta Thakerar
Legal AND Compliance consultancy professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore
Yuet Ming Tham, JD
Partner, Sidley Austin LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong
John Tsai
Forensic Partner, Fraud Investigation & Dispute Services, Ernst & Young (China) Advisory Limited, Shanghai, China
Mini vandePol, LLB
Attorney and Chair, Global Compliance and Investigations Group, Baker McKenzie, Hong Kong
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong
YanXiang (Michael) Wang, MBA
Country Director, China, PATH, Former Commercial Development Director, China, Becton Dickinson, Former Area Sales Manager, China, Boehringer Ingelheim, Former Area Assistant Manager, China, GlaxoSmithKline, Beijing, China
Joyce Wong
Managing Director, Polaris Asia-Pacific, Former General Manager, Eli Lilly Asia Inc., Hong Kong
Carol Wu
Third Party Audit, Asia, Global Ethics & Compliance, GSK, Former Manager, Ethics & Compliance- China, Hospira, Former Senior Compliance Manager, AstraZeneca, Shanghai, China
Pete (Lijun) Wu, MS, MBA
Country Chief Compliance Officer, Novartis Group (China), Shanghai, China
Vivian Wu, LLB, LLM
Counsel, Fenxun Partners, Former Partner, Baker McKenzie, Beijing, China
Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China
Henry Yao, MA
Head of Compliance, Roche Diagnostics; Former Asia Compliance Leader, GE Energy Management, Shanghai, China
Junjie Yao, PhD
Associate Professor, School of computer science and software engineering, Advanced Institute of Data Analysis, East China Normal University, Shanghai, China
Xi Zhang, LLM, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited, Former General Counsel Asia, Celanese, Shanghai, China
Mike Zhao, MBA
Ethics and Compliance Lead, China, UCB, Former Compliance Manager, Johnson & Johnson, Shanghai, China
2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 – 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
May 14 – 16, 2018
Hotel Savoyen
Vienna, Austria
www.InternationalPharmaCongress.com
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 2018
Singapore
www.AsianPharmaCongress.com
INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
International Society of Health-
care Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Fall 2018
Mumbai, India
Coming Soon
